Ondine Common Stock Shares Outstanding vs Accounts Payable Analysis

OBI Stock   8.25  0.12  1.48%   
Ondine Biomedical financial indicator trend analysis is much more than just breaking down Ondine Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ondine Biomedical is a good investment. Please check the relationship between Ondine Biomedical Common Stock Shares Outstanding and its Accounts Payable accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Common Stock Shares Outstanding vs Accounts Payable

Common Stock Shares Outstanding vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ondine Biomedical Common Stock Shares Outstanding account and Accounts Payable. At this time, the significance of the direction appears to have no relationship.
The correlation between Ondine Biomedical's Common Stock Shares Outstanding and Accounts Payable is 0.01. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Ondine Biomedical, assuming nothing else is changed. The correlation between historical values of Ondine Biomedical's Common Stock Shares Outstanding and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Ondine Biomedical are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Common Stock Shares Outstanding i.e., Ondine Biomedical's Common Stock Shares Outstanding and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.01
Relationship DirectionPositive 
Relationship StrengthInsignificant

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Ondine Biomedical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ondine Biomedical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Ondine Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ondine Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The current year's Issuance Of Capital Stock is expected to grow to about 9.1 M, whereas Selling General Administrative is forecasted to decline to about 7.8 M.
 2021 2022 2023 2024 (projected)
Interest Expense1.2M30K38K36.1K
Depreciation And Amortization514K493K587K517.3K

Ondine Biomedical fundamental ratios Correlations

-0.390.790.32-0.82-0.510.531.0-0.45-0.211.00.24-0.29-0.080.44-0.381.0-0.450.330.9-0.460.67-0.34-0.20.170.7
-0.39-0.87-0.090.850.07-0.47-0.380.1-0.33-0.390.280.510.290.051.0-0.390.990.34-0.240.99-0.40.17-0.360.36-0.3
0.79-0.870.21-0.99-0.290.590.78-0.290.110.79-0.08-0.48-0.230.17-0.860.78-0.89-0.060.62-0.890.63-0.270.13-0.130.57
0.32-0.090.21-0.29-0.660.120.36-0.74-0.040.370.45-0.06-0.120.79-0.070.38-0.160.620.33-0.170.55-0.8-0.070.070.66
-0.820.85-0.99-0.290.35-0.6-0.810.38-0.11-0.82-0.020.50.23-0.260.83-0.820.88-0.04-0.670.88-0.650.36-0.130.13-0.62
-0.510.07-0.29-0.660.35-0.66-0.490.510.66-0.5-0.56-0.280.02-0.90.05-0.540.16-0.6-0.670.17-0.790.420.63-0.57-0.85
0.53-0.470.590.12-0.6-0.660.5-0.28-0.420.510.240.01-0.110.44-0.470.53-0.530.070.68-0.530.64-0.13-0.430.410.69
1.0-0.380.780.36-0.81-0.490.5-0.52-0.151.00.27-0.33-0.080.46-0.361.0-0.430.360.89-0.440.65-0.4-0.150.130.7
-0.450.1-0.29-0.740.380.51-0.28-0.52-0.21-0.52-0.730.490.02-0.790.08-0.530.18-0.6-0.610.19-0.260.96-0.20.2-0.51
-0.21-0.330.11-0.04-0.110.66-0.42-0.15-0.21-0.15-0.2-0.78-0.07-0.38-0.34-0.18-0.28-0.34-0.33-0.28-0.53-0.350.98-0.91-0.47
1.0-0.390.790.37-0.82-0.50.511.0-0.52-0.150.28-0.34-0.080.47-0.371.0-0.440.360.9-0.450.65-0.41-0.140.120.7
0.240.28-0.080.45-0.02-0.560.240.27-0.73-0.20.28-0.06-0.110.770.30.30.180.830.560.170.16-0.62-0.180.130.36
-0.290.51-0.48-0.060.5-0.280.01-0.330.49-0.78-0.34-0.060.120.00.51-0.330.50.23-0.270.50.270.56-0.840.860.18
-0.080.29-0.23-0.120.230.02-0.11-0.080.02-0.07-0.08-0.110.12-0.010.28-0.080.290.0-0.080.29-0.10.07-0.080.08-0.07
0.440.050.170.79-0.26-0.90.440.46-0.79-0.380.470.770.0-0.010.070.5-0.050.720.67-0.060.54-0.73-0.340.270.7
-0.381.0-0.86-0.070.830.05-0.47-0.360.08-0.34-0.370.30.510.280.07-0.370.990.36-0.230.99-0.390.15-0.360.36-0.28
1.0-0.390.780.38-0.82-0.540.531.0-0.53-0.181.00.3-0.33-0.080.5-0.37-0.450.370.91-0.450.67-0.42-0.170.140.72
-0.450.99-0.89-0.160.880.16-0.53-0.430.18-0.28-0.440.180.50.29-0.050.99-0.450.24-0.331.0-0.470.23-0.310.32-0.38
0.330.34-0.060.62-0.04-0.60.070.36-0.6-0.340.360.830.230.00.720.360.370.240.460.230.44-0.51-0.370.370.55
0.9-0.240.620.33-0.67-0.670.680.89-0.61-0.330.90.56-0.27-0.080.67-0.230.91-0.330.46-0.330.58-0.45-0.280.210.69
-0.460.99-0.89-0.170.880.17-0.53-0.440.19-0.28-0.450.170.50.29-0.060.99-0.451.00.23-0.33-0.480.24-0.310.31-0.39
0.67-0.40.630.55-0.65-0.790.640.65-0.26-0.530.650.160.27-0.10.54-0.390.67-0.470.440.58-0.48-0.19-0.570.570.95
-0.340.17-0.27-0.80.360.42-0.13-0.40.96-0.35-0.41-0.620.560.07-0.730.15-0.420.23-0.51-0.450.24-0.19-0.350.36-0.4
-0.2-0.360.13-0.07-0.130.63-0.43-0.15-0.20.98-0.14-0.18-0.84-0.08-0.34-0.36-0.17-0.31-0.37-0.28-0.31-0.57-0.35-0.98-0.53
0.170.36-0.130.070.13-0.570.410.130.2-0.910.120.130.860.080.270.360.140.320.370.210.310.570.36-0.980.55
0.7-0.30.570.66-0.62-0.850.690.7-0.51-0.470.70.360.18-0.070.7-0.280.72-0.380.550.69-0.390.95-0.4-0.530.55
Click cells to compare fundamentals

Ondine Biomedical Account Relationship Matchups

Ondine Biomedical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.9M2.6M34.1M16.6M5.7M9.0M
Total Current Liabilities28.7M35.8M3.9M3.9M3.5M3.3M
Total Stockholder Equity(26.1M)(33.8M)29.7M11.6M2.1M2.2M
Property Plant And Equipment Net849K671K601K1.4M949K663.6K
Net Debt27.7M30.8M(29.6M)(12.2M)(2.4M)(2.3M)
Retained Earnings(165.9M)(182.1M)(232.5M)(251.9M)(266.3M)(253.0M)
Accounts Payable183K237K1.2M388K1.4M923.0K
Cash306K626K30.4M13.1M3.0M4.5M
Non Current Assets Total1.9M888K636K1.4M984K1.3M
Non Currrent Assets Other42K40K46K35K36K33.3K
Cash And Short Term Investments306K626K30.4M13.1M3.0M5.6M
Net Receivables24K543K248K133K220K269.6K
Liabilities And Stockholders Equity2.9M2.6M34.1M16.6M5.7M9.0M
Non Current Liabilities Total316K678K561K1.0M159K151.1K
Other Stockholder Equity20.3M28.8M27.2M28.5M28.8M33.0M
Total Liab29.0M36.5M4.5M4.9M3.6M3.5M
Total Current Assets1.0M1.7M33.5M15.1M4.8M7.7M
Short Long Term Debt Total28.0M31.5M739K896K541K514.0K
Other Current Liab760K4.2M2.1M3.2M1.7M1.0M
Other Current Assets236K717K2.1M710K703K1.1M
Short Term Debt27.7M31.4M645K359K382K362.9K
Inventory468K404K1.1M1.3M1.1M646.2K
Capital Lease Obligations569K310K242K896K541K469.7K
Net Invested Capital1.4M334K30.2M11.6M2.1M2.0M
Net Working Capital(27.7M)(34.0M)29.6M11.2M1.3M1.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ondine Stock

Balance Sheet is a snapshot of the financial position of Ondine Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Ondine Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ondine Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ondine currently owns. An asset can also be divided into two categories, current and non-current.